SCHEMBL20028678

SCHEMBL20028678

Cc1nc(-c2ccccc2)c(C(=O)O)o1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.52
POLB P06746 3/20 0.52
TSHR P16473 2/20 0.52
USP2 O75604 2/20 0.52
HTT P42858 2/20 0.52
HSD17B10 Q99714 2/20 0.52
MAPK13 O15264 1/20 0.50
MAPK12 P53778 1/20 0.50
MAPK11 Q15759 1/20 0.50
MAPK14 Q16539 1/20 0.50
ALDH1A1 P00352 3/20 0.49
KDM4E B2RXH2 3/20 0.49
NR4A2 P43354 3/20 0.49
PTGS2 P35354 1/20 0.48
KMT2A Q03164 3/20 0.47
GAA P10253 1/20 0.46
PDE10A Q9Y233 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 2/20 0.44
MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5008392 0.86 KDM4E (0.58) MAPTPOLBTSHRUSP2HTT
SCHEMBL14709099 0.85 RXFP1 (0.45) MAPTPOLBTSHRUSP2HTT
SCHEMBL4719656 0.85 PTGS2 (0.50) MAPTPOLBTSHRUSP2HTT
SCHEMBL3822654 0.83 KDM4E (0.55) MAPTPOLBTSHRUSP2HTT
SCHEMBL20028185 0.83 NR4A1 (0.48) MAPTPOLBTSHRUSP2HTT
SCHEMBL28306041 0.83 HSD17B10 (0.45) MAPTPOLBTSHRUSP2HTT
SCHEMBL20028674 0.81 ADORA3 (0.58) MAPTHSD17B10ALDH1A1KDM4EKMT2A
SCHEMBL6334543 0.80 GAA (0.55) MAPTPOLBHSD17B10ALDH1A1KDM4E
SCHEMBL20028760 0.79 KDM4E (0.47) MAPTPOLBTSHRUSP2HTT
SCHEMBL20027762 0.79 MAPT (0.47) MAPTPOLBTSHRUSP2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11339130-B1 Calpain modulators and therapeutic uses thereof BLADE THERAPEUTICS, INC. (US) 2022-05-24 US disclosed
US-10934261-B2 Calpain modulators and therapeutic uses thereof BLADE THERAPEUTICS, INC. (US) 2021-03-02 US disclosed
US-10894776-B2 2021-01-19 US disclosed
WO-2018064119-A1 CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF BLADE THERAPEUTICS, INC. (US) 2018-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10934261-B2 Calpain modulators and therapeutic uses thereof CAPNS1, CAPN9, CAPN1 MAPT 562/4885POLB 2724/4885TSHR 4380/4885
US-10894776-B2 CAPNS1, CAPN9, CAPN2 MAPT 330/4885POLB 2408/4885TSHR 4691/4885
US-11339130-B1 Calpain modulators and therapeutic uses thereof CAPNS1, CAPN9, CAPN1 MAPT 562/4885POLB 2724/4885TSHR 4380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.